take in healthy volunteers: Am J Physiol Endocrinol Metab 281:E155–E161, 2001 36. Kolterman O, Gottlieb A, Gaines E, Fine- man M: Five-day dosing of synthetic ex-endin-4 (AC2993) in people with type 2diabetes reduces postprandial glucose, glucagon and triglyceride concentrations(Abstract). Diabetologia 43 (Suppl. 1): A189, 2000 37. Ryan AS, Egan JM, Habener JF, Elahi D:Insulinotropic hormone glucagon-like peptide-1-(7-37) appears not to augmentinsulin-mediated glucose uptake inyoung men during euglycemia. J Clin En- docrinol Metab 83:2399–2404, 1998Fineman and Associates DIABETES CARE,VOLUME 26, NUMBER 8, A UGUST 2003 2377Downloaded from http://diabetesjournals.org/care/article-pdf/26/8/2370/660914/dc08030023 0.pdf by guest on 17 January 2024